TY - JOUR
T1 - Supplementation of highly concentrated β-cryptoxanthin in a satsuma mandarin beverage improves adipocytokine profiles in obese Japanese women
AU - Iwamoto, Masako
AU - Imai, Katsumi
AU - Ohta, Hideaki
AU - Shirouchi, Bungo
AU - Sato, Masao
PY - 2012
Y1 - 2012
N2 - Background: Serum β-cryptoxanthin levels are lower in overweight subjects than in normal subjects. Abnormalities of adipocytokine profiles in obesity subjects have been reported. There are several reports that serum β-cryptoxanthin levels in them were relatively lower than normal subjects. Objective. We hypothesize that supplementation of highly concentrated β-cryptoxanthin improves serum adipocytokine profiles in obese subjects. This study tested the association between β-cryptoxanthin intake and serum adipocytokine levels. Methods. An intervention study consisted of a 3-week long before-and-after controlled trial, where β-cryptoxanthin (4.7mg/day) was given to 17 moderately obese postmenopausal women. Results: The results indicated no significant changes in body weight or body mass index (BMI). Serum β-cryptoxanthin levels increased significantly by 4-fold. Serum high molecular weight (HMW)-adiponectin levels increased significantly, while serum plasminogen activator inhibitor (PAI)-1 levels decreased. Conclusions: We concluded that increasing the intake of β-cryptoxanthin to approximately 4mg per day for 3weeks may have beneficial effects on the serum adipocytokine status and consequently alleviate progression of metabolic syndrome.
AB - Background: Serum β-cryptoxanthin levels are lower in overweight subjects than in normal subjects. Abnormalities of adipocytokine profiles in obesity subjects have been reported. There are several reports that serum β-cryptoxanthin levels in them were relatively lower than normal subjects. Objective. We hypothesize that supplementation of highly concentrated β-cryptoxanthin improves serum adipocytokine profiles in obese subjects. This study tested the association between β-cryptoxanthin intake and serum adipocytokine levels. Methods. An intervention study consisted of a 3-week long before-and-after controlled trial, where β-cryptoxanthin (4.7mg/day) was given to 17 moderately obese postmenopausal women. Results: The results indicated no significant changes in body weight or body mass index (BMI). Serum β-cryptoxanthin levels increased significantly by 4-fold. Serum high molecular weight (HMW)-adiponectin levels increased significantly, while serum plasminogen activator inhibitor (PAI)-1 levels decreased. Conclusions: We concluded that increasing the intake of β-cryptoxanthin to approximately 4mg per day for 3weeks may have beneficial effects on the serum adipocytokine status and consequently alleviate progression of metabolic syndrome.
UR - http://www.scopus.com/inward/record.url?scp=84860827207&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84860827207&partnerID=8YFLogxK
U2 - 10.1186/1476-511X-11-52
DO - 10.1186/1476-511X-11-52
M3 - Article
C2 - 22584034
AN - SCOPUS:84860827207
SN - 1476-511X
VL - 11
JO - Lipids in Health and Disease
JF - Lipids in Health and Disease
M1 - 52
ER -